Elodie Montaudon et al.
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
Nature Communications 2020, vol. 11, issue 1
doi: 10.1038/s41467-020-17697-1